MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
468.65%
Quick Ratio
407.13%
Cash Ratio
81.13%
Debt to Asset Ratio
27.05%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Trade accounts receivable, net
    • Inventories
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Deferred revenue, current
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
65,665 90,853 93,281 75,470
Restricted cash
NaN 0 0 0
Marketable securities
196,560 170,676 168,453 186,552
Trade accounts receivable, net
51,903 62,509 56,632 56,232
Inventories
49,791 48,428 51,649 49,487
Prepaid expenses and other current assets
15,383 19,530 18,474 15,084
Total current assets
379,302 391,996 388,489 382,825
Deferred income tax assets, noncurrent
NaN 0 38,393 35,765
Property and equipment, net
20,469 18,009 18,046 18,352
Operating lease right-of-use assets
10,643 11,315 11,158 16,387
Goodwill
16,689 16,697 16,698 16,707
Intangible assets, net
15,704 16,821 17,676 18,601
Other noncurrent assets
6,306 6,704 4,459 4,683
Total assets
449,113 461,542 494,919 493,320
Trade accounts payable
6,741 6,410 7,632 6,853
Legal settlement liability, current
2,208 2,495 2,177 1,968
Accrued expenses
19,781 23,417 20,233 21,604
Other current liabilities
22,173 16,978 16,426 14,717
Deferred revenue, current
30,032 28,504 28,739 28,128
Total current liabilities
80,935 77,804 75,207 73,270
Legal settlement liability, noncurrent
6,637 6,786 8,158 8,477
Deferred revenue, noncurrent
17,672 18,339 16,315 16,625
Operating lease liability, noncurrent
13,441 14,042 13,494 14,119
Long-term debt
386 525 655 791
Other noncurrent liabilities
2,398 2,307 2,519 2,481
Total liabilities
121,469 119,803 116,348 115,763
Common stock, 0.001 par value 1,000,000,000 authorized shares as of march31, 2026 and december31, 2025, respectively 129,142,587 and 128,550,136 issued and outstanding shares as of march31, 2026 and december31, 2025, respectively
129 129 128 127
Additional paid-in capital
445,750 441,107 435,284 429,652
Accumulated deficit
-120,604 -101,738 -57,662 -52,184
Accumulated other comprehensive gain
2,369 2,241 821 -38
Total stockholders equity
327,644 341,739 378,571 377,557
Total liabilities and stockholders equity
449,113 461,542 494,919 493,320
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$196,560K Cash and cashequivalents$65,665K Trade accountsreceivable, net$51,903K Inventories$49,791K Prepaid expenses andother current assets$15,383K Total current assets$379,302K Property and equipment,net$20,469K Goodwill$16,689K Intangible assets, net$15,704K Operating leaseright-of-use assets$10,643K Other noncurrentassets$6,306K Total assets$449,113K Total liabilities andstockholders equity$449,113K Total stockholdersequity$327,644K Total liabilities$121,469K Accumulated deficit-$120,604K Additional paid-in capital$445,750K Total currentliabilities$80,935K Deferred revenue,noncurrent$17,672K Operating leaseliability, noncurrent$13,441K Legal settlementliability, noncurrent$6,637K Other noncurrentliabilities$2,398K Long-term debt$386K Accumulated othercomprehensive gain$2,369K Common stock, 0.001 parvalue 1,000,000,000...$129K Deferred revenue,current$30,032K Other currentliabilities$22,173K Accrued expenses$19,781K Trade accountspayable$6,741K Legal settlementliability, current$2,208K

Cytek Biosciences, Inc. (CTKB)

Cytek Biosciences, Inc. (CTKB)